{
    "organizations": [],
    "uuid": "32efc81b18471aa49bbe9a08591e5a375c52abd7",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-cerenis-therapeutics-acquires-lypr/brief-cerenis-therapeutics-acquires-lypro-biosciences-idUSFWN1PK1GC",
    "ord_in_thread": 0,
    "title": "BRIEF-Cerenis Therapeutics Acquires Lypro Biosciences‍​",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Jan 25 (Reuters) - Cerenis Therapeutics Holding Sa :\n* CASH POSITION AT END DEC 2017 EUR 16.3 MLN‍​ * ACQUIRES LYPRO BIOSCIENCES * INCLUSION OF THE FIRST PATIENTS IN THE TARGET STUDY * END OF PHASE III PATIENT RECRUITMENT IN TANGO Source text for Eikon: Further company coverage: (Gdynia Newsroom)\n ",
    "published": "2018-01-26T01:20:00.000+02:00",
    "crawled": "2018-01-26T21:20:56.002+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "jan",
        "reuters",
        "cerenis",
        "therapeutic",
        "holding",
        "sa",
        "cash",
        "position",
        "end",
        "dec",
        "eur",
        "acquires",
        "lypro",
        "bioscience",
        "inclusion",
        "first",
        "patient",
        "target",
        "study",
        "end",
        "phase",
        "iii",
        "patient",
        "recruitment",
        "tango",
        "source",
        "text",
        "eikon",
        "company",
        "coverage",
        "gdynia",
        "newsroom"
    ]
}